CN111201026B - 具有癌性恶病质抑制作用的发酵乳和多糖类 - Google Patents

具有癌性恶病质抑制作用的发酵乳和多糖类 Download PDF

Info

Publication number
CN111201026B
CN111201026B CN201880064288.5A CN201880064288A CN111201026B CN 111201026 B CN111201026 B CN 111201026B CN 201880064288 A CN201880064288 A CN 201880064288A CN 111201026 B CN111201026 B CN 111201026B
Authority
CN
China
Prior art keywords
cancer cachexia
fermented milk
cancer
lactobacillus delbrueckii
bulgaricus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880064288.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN111201026A (zh
Inventor
川锅启诚
中村真梨枝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Co Ltd
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of CN111201026A publication Critical patent/CN111201026A/zh
Application granted granted Critical
Publication of CN111201026B publication Critical patent/CN111201026B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CN201880064288.5A 2017-10-31 2018-10-29 具有癌性恶病质抑制作用的发酵乳和多糖类 Active CN111201026B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017-210401 2017-10-31
JP2017210401A JP7065589B2 (ja) 2017-10-31 2017-10-31 ＩＬ－１β血清濃度低下用発酵乳、ＣＸＣＬ１血清濃度低下用発酵乳、癌に伴うＩＬ－１βの過度な血清濃度上昇の抑制用発酵乳、または、癌に伴うＣＸＣＬ１の過度な血清濃度上昇の抑制用発酵乳
PCT/JP2018/040016 WO2019087993A1 (ja) 2017-10-31 2018-10-29 癌性悪液質抑制作用を有する発酵乳および多糖類

Publications (2)

Publication Number Publication Date
CN111201026A CN111201026A (zh) 2020-05-26
CN111201026B true CN111201026B (zh) 2023-09-19

Family

ID=66331935

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880064288.5A Active CN111201026B (zh) 2017-10-31 2018-10-29 具有癌性恶病质抑制作用的发酵乳和多糖类

Country Status (4)

Country Link
US (1) US11638431B2 (enExample)
JP (1) JP7065589B2 (enExample)
CN (1) CN111201026B (enExample)
WO (1) WO2019087993A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7065589B2 (ja) 2017-10-31 2022-05-12 株式会社明治 ＩＬ－１β血清濃度低下用発酵乳、ＣＸＣＬ１血清濃度低下用発酵乳、癌に伴うＩＬ－１βの過度な血清濃度上昇の抑制用発酵乳、または、癌に伴うＣＸＣＬ１の過度な血清濃度上昇の抑制用発酵乳
CN113861303B (zh) * 2021-10-21 2023-04-21 华南理工大学 一种从德氏乳杆菌和嗜热链球菌发酵酸奶中分离出的胞外多糖及其应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025174A1 (en) * 1995-02-13 1996-08-22 Chugai Seiyaku Kabushiki Kaisha Muscle protein decomposition inhibitor containing il-6 receptor antibody
WO2007140613A1 (en) * 2006-06-06 2007-12-13 Mcgill University Fermented milk product and use thereof
JP2011139700A (ja) * 2009-12-09 2011-07-21 Meiji Co Ltd 乳酸菌のスクリーニング方法、当該方法により選抜された乳酸菌、並びにその乳酸菌を含む抗ウイルス剤及び飲食品組成物
JP2012526757A (ja) * 2009-05-11 2012-11-01 ネステク ソシエテ アノニム プロバイオティクスを含有する、栄養的にバランスのとれた標準的経管栄養用調合乳
JP2014027925A (ja) * 2012-06-25 2014-02-13 Meiji Co Ltd 菌体外多糖産生乳酸菌用培地、菌体外多糖産生菌の製造方法、菌体外多糖、菌体外多糖の製造方法、及びヨーグルトの製造方法
CN104905246A (zh) * 2015-04-24 2015-09-16 劲膳美生物科技股份有限公司 恶性肿瘤特定全营养配方食品
WO2017135364A1 (ja) * 2016-02-03 2017-08-10 株式会社明治 発酵乳の製造方法及び発酵乳
WO2018194149A1 (ja) * 2017-04-21 2018-10-25 株式会社明治 サイトカイン産生制御剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009537582A (ja) 2006-05-24 2009-10-29 ディーエスエム アイピー アセッツ ビー．ブイ． 有機化合物の新しい用途
US7901925B2 (en) * 2006-06-23 2011-03-08 Bojrab Gregory G Lactobacillus delbrueckii ssp. bulgaricus strain and compositions
EP2203551B1 (en) 2007-10-20 2013-08-21 Université de Liège Bifidobacterial species
AU2009240643B2 (en) 2008-04-23 2014-03-06 Rigel Pharmaceuticals, Inc. Carboxamide compounds for the treatment of metabolic disorders
CA2818467A1 (en) 2009-11-18 2011-05-26 Murray Goulburn Co-Operative Co. Limited Recombinant microorganisms
US9585920B2 (en) * 2011-02-04 2017-03-07 Katherine Rose Kovarik Method and system for treating cancer cachexia
BG66937B1 (bg) * 2012-03-07 2019-08-15 "Дафлорн" Оод Асоциация от пробиотични млечнокисели микроорганизми за получаване на диетични млечни продукти
CA2921820C (en) * 2013-08-26 2021-10-12 Meiji Co., Ltd. Antibody titer-increasing agent using lactic acid bacterium
JP7065589B2 (ja) 2017-10-31 2022-05-12 株式会社明治 ＩＬ－１β血清濃度低下用発酵乳、ＣＸＣＬ１血清濃度低下用発酵乳、癌に伴うＩＬ－１βの過度な血清濃度上昇の抑制用発酵乳、または、癌に伴うＣＸＣＬ１の過度な血清濃度上昇の抑制用発酵乳

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025174A1 (en) * 1995-02-13 1996-08-22 Chugai Seiyaku Kabushiki Kaisha Muscle protein decomposition inhibitor containing il-6 receptor antibody
WO2007140613A1 (en) * 2006-06-06 2007-12-13 Mcgill University Fermented milk product and use thereof
JP2012526757A (ja) * 2009-05-11 2012-11-01 ネステク ソシエテ アノニム プロバイオティクスを含有する、栄養的にバランスのとれた標準的経管栄養用調合乳
JP2011139700A (ja) * 2009-12-09 2011-07-21 Meiji Co Ltd 乳酸菌のスクリーニング方法、当該方法により選抜された乳酸菌、並びにその乳酸菌を含む抗ウイルス剤及び飲食品組成物
JP2014027925A (ja) * 2012-06-25 2014-02-13 Meiji Co Ltd 菌体外多糖産生乳酸菌用培地、菌体外多糖産生菌の製造方法、菌体外多糖、菌体外多糖の製造方法、及びヨーグルトの製造方法
CN104905246A (zh) * 2015-04-24 2015-09-16 劲膳美生物科技股份有限公司 恶性肿瘤特定全营养配方食品
WO2017135364A1 (ja) * 2016-02-03 2017-08-10 株式会社明治 発酵乳の製造方法及び発酵乳
WO2018194149A1 (ja) * 2017-04-21 2018-10-25 株式会社明治 サイトカイン産生制御剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
微生态制剂对食管癌术后患者消化道并发症及营养状况临床疗效的随机对照试验;李东航等;《中国胸心血管外科临床杂志》(第03期);第312-317页 *

Also Published As

Publication number Publication date
CN111201026A (zh) 2020-05-26
JP7065589B2 (ja) 2022-05-12
US11638431B2 (en) 2023-05-02
US20200296979A1 (en) 2020-09-24
WO2019087993A1 (ja) 2019-05-09
JP2019081733A (ja) 2019-05-30

Similar Documents

Publication Publication Date Title
JP7516053B2 (ja) 組成物並びに飲食品組成物、栄養組成物および調製乳
JP6329125B2 (ja) ストレス軽減剤
EP3442549B1 (en) Bifidobacteria for increasing lean body mass
JP5925274B2 (ja) 子宮内膜症の予防及び／又は改善剤及びこれを含んでなる飲食品組成物
JP2023175938A (ja) 糖代謝改善用組成物
EP3442550B1 (en) Bifidobacteria for reducing food, energy and/or fat intake
JP2024091698A (ja) 抗ストレス用組成物
JP6916042B2 (ja) 抗原特異的インターフェロンγ産生促進用組成物
CN111201026B (zh) 具有癌性恶病质抑制作用的发酵乳和多糖类
WO2010061877A1 (ja) ミネラル吸収改善剤およびミネラル吸収改善方法
JP7433220B2 (ja) 月経随伴症状の処置のための組成物
JP2021107400A (ja) 肥満抑制剤
JP2019081733A5 (enExample)
JP2011239774A (ja) 満腹感誘導組成物
JP7181954B2 (ja) 高いＡｈＲ活性化能を有する乳酸菌
EP3479836B1 (en) Cartilage regeneration facilitating composition
JPWO2019180964A1 (ja) Ｆｇｆ２１分泌促進用組成物
WO2018151245A1 (ja) インターロイキン－２３産生促進用組成物およびインターロイキン－２３の産生促進方法
KR102691618B1 (ko) 발효유 및 유청단백질 가수분해물을 포함하는 프로바이오틱스 조성물
JP2021045054A (ja) 抗憂うつ用組成物、幸福感向上用組成物
JP2019187264A (ja) 糖代謝異常の予防および改善用組成物
CN120225074A (zh) 肌肉肌醇和预防加速生长
JP2023126304A (ja) 腎機能障害予防又は改善用組成物、並びに、該腎機能障害予防又は改善用組成物を用いた医薬品組成物及び飲食品組成物
JP2021042141A (ja) 腎機能障害の予防又は改善用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
HK1158060B (en) Mineral absorption improver, and method for improving absorption of minerals

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant